These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20461448)

  • 21. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state.
    Sun M; Chen M; Dawood F; Zurawska U; Li JY; Parker T; Kassiri Z; Kirshenbaum LA; Arnold M; Khokha R; Liu PP
    Circulation; 2007 Mar; 115(11):1398-407. PubMed ID: 17353445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction.
    van Rooij E; Doevendans PA; Crijns HJ; Heeneman S; Lips DJ; van Bilsen M; Williams RS; Olson EN; Bassel-Duby R; Rothermel BA; De Windt LJ
    Circ Res; 2004 Feb; 94(3):e18-26. PubMed ID: 14739160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted cardiac overexpression of A20 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
    Li HL; Zhuo ML; Wang D; Wang AB; Cai H; Sun LH; Yang Q; Huang Y; Wei YS; Liu PP; Liu DP; Liang CC
    Circulation; 2007 Apr; 115(14):1885-94. PubMed ID: 17389268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.
    Streicher JM; Ren S; Herschman H; Wang Y
    Circ Res; 2010 Apr; 106(8):1434-43. PubMed ID: 20339119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MK5 haplodeficiency attenuates hypertrophy and preserves diastolic function during remodeling induced by chronic pressure overload in the mouse heart.
    Nawaito SA; Dingar D; Sahadevan P; Hussein B; Sahmi F; Shi Y; Gillis MA; Gaestel M; Tardif JC; Allen BG
    Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H46-H58. PubMed ID: 28432058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different roles of BAG3 in cardiac physiological hypertrophy and pathological remodeling.
    Jia P; Wu N; Yang H; Guo Y; Guo X; Sun Y
    Transl Res; 2021 Jul; 233():47-61. PubMed ID: 33578031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted activation of c-Jun N-terminal kinase in vivo induces restrictive cardiomyopathy and conduction defects.
    Petrich BG; Eloff BC; Lerner DL; Kovacs A; Saffitz JE; Rosenbaum DS; Wang Y
    J Biol Chem; 2004 Apr; 279(15):15330-8. PubMed ID: 14742426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sprouty1 is a critical regulatory switch of mesenchymal stem cell lineage allocation.
    Urs S; Venkatesh D; Tang Y; Henderson T; Yang X; Friesel RE; Rosen CJ; Liaw L
    FASEB J; 2010 Sep; 24(9):3264-73. PubMed ID: 20410440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac-specific PID1 overexpression enhances pressure overload-induced cardiac hypertrophy in mice.
    Liu Y; Shen Y; Zhu J; Liu M; Li X; Chen Y; Kong X; Song G; Qian L
    Cell Physiol Biochem; 2015; 35(5):1975-85. PubMed ID: 25871431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical role of Rho-kinase pathway for cardiac performance and remodeling in failing rat hearts.
    Kobayashi N; Horinaka S; Mita S; Nakano S; Honda T; Yoshida K; Kobayashi T; Matsuoka H
    Cardiovasc Res; 2002 Sep; 55(4):757-67. PubMed ID: 12176125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of miR-29b suppresses MAPK signaling pathway through targeting SPRY1 in atherosclerosis.
    Lu Z; Wang F; Yu P; Wang X; Wang Y; Tang ST; Zhu HQ
    Vascul Pharmacol; 2018 Mar; 102():29-36. PubMed ID: 29398368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NF-kappaB activation is required for adaptive cardiac hypertrophy.
    Zelarayan L; Renger A; Noack C; Zafiriou MP; Gehrke C; van der Nagel R; Dietz R; de Windt L; Bergmann MW
    Cardiovasc Res; 2009 Dec; 84(3):416-24. PubMed ID: 19620128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SH2B1 is critical for the regulation of cardiac remodelling in response to pressure overload.
    Wu G; Liu Y; Huang H; Tang Y; Liu W; Mei Y; Wan N; Liu X; Huang C
    Cardiovasc Res; 2015 Jul; 107(2):203-15. PubMed ID: 26077624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium.
    Rawal S; Nagesh PT; Coffey S; Van Hout I; Galvin IF; Bunton RW; Davis P; Williams MJA; Katare R
    Cardiovasc Diabetol; 2019 Jan; 18(1):13. PubMed ID: 30696455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sprouty1 induces a senescence-associated secretory phenotype by regulating NFκB activity: implications for tumorigenesis.
    Macià A; Vaquero M; Gou-Fàbregas M; Castelblanco E; Valdivielso JM; Anerillas C; Mauricio D; Matias-Guiu X; Ribera J; Encinas M
    Cell Death Differ; 2014 Feb; 21(2):333-43. PubMed ID: 24270409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Load-induced transcriptional activation of c-jun in rat myocardium: regulation by myocyte enhancer factor 2.
    Nadruz W; Kobarg CB; Constancio SS; Corat PD; Franchini KG
    Circ Res; 2003 Feb; 92(2):243-51. PubMed ID: 12574153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced expression of β3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase.
    Belge C; Hammond J; Dubois-Deruy E; Manoury B; Hamelet J; Beauloye C; Markl A; Pouleur AC; Bertrand L; Esfahani H; Jnaoui K; Götz KR; Nikolaev VO; Vanderper A; Herijgers P; Lobysheva I; Iaccarino G; Hilfiker-Kleiner D; Tavernier G; Langin D; Dessy C; Balligand JL
    Circulation; 2014 Jan; 129(4):451-62. PubMed ID: 24190960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MAP kinase kinase 6-p38 MAP kinase signaling cascade regulates cyclooxygenase-2 expression in cardiac myocytes in vitro and in vivo.
    Degousee N; Martindale J; Stefanski E; Cieslak M; Lindsay TF; Fish JE; Marsden PA; Thuerauf DJ; Glembotski CC; Rubin BB
    Circ Res; 2003 Apr; 92(7):757-64. PubMed ID: 12649265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic regulation of MEK/Erks and Akt/GSK-3beta in human end-stage heart failure after left ventricular mechanical support: myocardial mechanotransduction-sensitivity as a possible molecular mechanism.
    Baba HA; Stypmann J; Grabellus F; Kirchhof P; Sokoll A; Schäfers M; Takeda A; Wilhelm MJ; Scheld HH; Takeda N; Breithardt G; Levkau B
    Cardiovasc Res; 2003 Aug; 59(2):390-9. PubMed ID: 12909322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blockade of PAR-1 Signaling Attenuates Cardiac Hypertrophy and Fibrosis in Renin-Overexpressing Hypertensive Mice.
    Yokono Y; Hanada K; Narita M; Tatara Y; Kawamura Y; Miura N; Kitayama K; Nakata M; Nozaka M; Kato T; Kudo N; Tsushima M; Toyama Y; Itoh K; Tomita H
    J Am Heart Assoc; 2020 Jun; 9(12):e015616. PubMed ID: 32495720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.